Search ResultsElectronic Resources 
by
Liu, Xuxiang, author.
Format:
Excerpt:
. Current therapeutic drugs mainly focus on the inhibition of this vicious cycle, but only have palliative
by
Kandar, Bojidar M., author.
Format:
Excerpt:
efficacy of DNA-damaging chemotherapeutic drugs. The Toll-like receptor 5 (TLR5) agonist, Entolimod, has
by
Rojas, Juan D., author.
Format:
Excerpt:
, and often lags behind the real effect of the drugs.
by
Shee, Kevin, author.
Format:
Excerpt:
cancer drugs, and that targeting FGF2 in combination with anti-estrogen therapy represents a combination
by
Forsythe, Steven, author.
Format:
Excerpt:
recalled drugs, and chemotherapeutics. and charted the response of the organoids to these compounds. With
by
Abraham, Pranav Samuel, author.
Format:
Excerpt:
insurance received the highest number of unit doses of drugs, while patients with private insurance received
by
Stocke, Nathanael A., author.
Format:
Excerpt:
lines A549 and H358 and compared with the free form of the drugs in order to evaluate the effectiveness
by
Ng, Antony K. M., author.
Format:
Excerpt:
provides a model that may help to understand the genotoxic and leukaemogenic effects of these drugs. This
by
Cresswell, Gregory Micheal, author.
Format:
Excerpt:
delivery of folate conjugated drugs. In this study, it was determined that FRbeta marks a population of
by
Hartley, Genevieve, author.
Format:
Excerpt:
patient groups, and at the same time, drugs that are ineffective in humans are also ineffective for dogs
by
Gbadebo, Akintunde J., author.
Format:
Excerpt:
for the development of novel synthetic anticancer drugs.
by
Erler, Janine, author.
Format:
Excerpt:
chemotherapeutic drugs, although incubation of cells from the panel of cell lines under anoxic conditions for 16h

Select an Action





